Hemofarm’s 66 years of dedication

Hemofarm, the leading pharmaceutical company in the region, has marked 66 years of operation and 20 years since becoming part of the STADA Group, one of the global leaders in generic and OTC medicines.

Over the past two decades, the Group has invested 537 million euros in the development of Hemofarm in the region, enabling the modernization of production capacities, the introduction of cutting‑edge technologies, and the further strengthening of the company’s competitiveness on the global market.

“Sixty‑six years of existence confirm our continuity and our ability to grow and adapt to new times and trends. We are proud to have been part of the STADA Group for two decades, a period marked by strong investment, technological progress, and the expansion of our operations. We continuously bring the latest therapeutic trends from around the world to our markets, improve formulations, and introduce new, innovative medicines in order to live up to our role as a reliable partner in protecting people’s health. We have record‑high medicine production, while at the same time preserving natural resources and operating in line with the principles of sustainable development,” said Hemofarm’s CEO, Ronald Seeliger.

Hemofarm is intensively enhancing the sustainability of its operations, and one of the most important projects in this area is the installation of solar panels at its plant in Vršac. This project is an important step toward increasing energy efficiency and relying more on renewable energy sources, thereby further reducing the company’s environmental footprint and confirming its long-term commitment to responsible business practices.

Continuous investment in employees and in the development of organizational culture has been confirmed by prestigious TOP Employer certificates, placing the company among the most attractive employers in the country and the region. At the same time, Hemofarm is strengthening its brands and market presence, both through the development of new product lines such as One Two Three and EUNOVA, and through a strategic focus on portfolio expansion and new therapeutic solutions.

Founded in 1960 in Vršac, Hemofarm has, over more than six decades, grown into a company with a strong regional and international presence. Today, it employs over 4,400 people and produces hundreds of millions of packages of medicines and dietary supplements each year. Its rich portfolio includes more than 400 products across different therapeutic groups.

Through the work of Hemofarm and the Hemofarm Foundation, the company continuously raises awareness about the importance of prevention, mental health, and access to healthcare, remaining true to its mission of improving the quality of life in the communities in which it operates.

The celebration of the company’s 66th anniversary was, as tradition dictates, accompanied by the organization of Family Day, an event that brings together employees and their families and further strengthens the values of togetherness and team spirit, which have remained one of the foundations of Hemofarm’s corporate culture for decades.